AGAPE ATP CORP (ATPC)
US0083891087 - Common Stock
We assign a fundamental rating of 2 out of 10 to ATPC. ATPC was compared to 115 industry peers in the Health Care Providers & Services industry. ATPC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ATPC is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year ATPC has reported negative net income.
ATPC had a negative operating cash flow in the past year.
ATPC had negative earnings in 4 of the past 5 years.
ATPC had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -57.56%, ATPC is doing worse than 88.60% of the companies in the same industry.
Looking at the Return On Equity, with a value of -76.30%, ATPC is doing worse than 74.56% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -57.56% | ||
| ROE | -76.3% | ||
| ROIC | N/A |
ROA(3y)-50.18%
ROA(5y)-31.34%
ROE(3y)-77.99%
ROE(5y)-47.89%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 63.67%, ATPC belongs to the top of the industry, outperforming 85.96% of the companies in the same industry.
ATPC's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for ATPC so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 63.67% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.55%
GM growth 5Y45.02%
2. Health
2.1 Basic Checks
ATPC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ATPC has less shares outstanding
Compared to 5 years ago, ATPC has less shares outstanding
The debt/assets ratio for ATPC is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.73, we must say that ATPC is in the distress zone and has some risk of bankruptcy.
ATPC has a Altman-Z score of 0.73. This is in the lower half of the industry: ATPC underperforms 62.28% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that ATPC is not too dependend on debt financing.
ATPC has a Debt to Equity ratio of 0.02. This is amongst the best in the industry. ATPC outperforms 82.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.73 |
ROIC/WACCN/A
WACC8.89%
2.3 Liquidity
A Current Ratio of 4.72 indicates that ATPC has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.72, ATPC belongs to the best of the industry, outperforming 93.86% of the companies in the same industry.
ATPC has a Quick Ratio of 4.66. This indicates that ATPC is financially healthy and has no problem in meeting its short term obligations.
ATPC has a Quick ratio of 4.66. This is amongst the best in the industry. ATPC outperforms 93.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.72 | ||
| Quick Ratio | 4.66 |
3. Growth
3.1 Past
The earnings per share for ATPC have decreased strongly by -2664.35% in the last year.
ATPC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -20.07%.
Measured over the past years, ATPC shows a very strong growth in Revenue. The Revenue has been growing by 23.91% on average per year.
EPS 1Y (TTM)-2664.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-20.07%
Revenue growth 3Y-25.42%
Revenue growth 5Y23.91%
Sales Q2Q%4.35%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
ATPC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for ATPC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AGAPE ATP CORP
NASDAQ:ATPC (10/29/2024, 8:00:01 PM)
After market: 1.67 0 (0%)1.67
-0.23 (-12.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.43M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -57.56% | ||
| ROE | -76.3% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 63.67% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 4.72 | ||
| Quick Ratio | 4.66 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-2664.35%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-20.07%
Revenue growth 3Y-25.42%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y